COPD

Aus PlusPedia
Wechseln zu: Navigation, Suche
Entstehender Artikel
Freie Übersichtsartikel [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80][81][82][83][84][85][86][87][88][89][90][91][92][93]
Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme
Was ist das
Struktur
Physiologie
Knockout
Transgen
Mutation
Polymorphismus
Genexpression
Inhibitoren
Agonisten


1 Bibliographie

  1. ↑ Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 87(3):1047-82 (2007) PMID 17615396
  2. ↑ Cost-effectiveness of long-term oxygen therapy for chronic obstructive disease. Am J Manag Care 15(2):97-104 (2009) PMID 19284806
  3. ↑ An assessment of therapeutic regimens in the treatment of acute exacerbations in chronic obstructive pulmonary disease and asthma. Am J Manag Care 10(5 Suppl):S139-52 (2004) PMID 15354679
  4. ↑ Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma. Am J Manag Care 10(5 Suppl):S129-38 (2004) PMID 15354678
  5. ↑ The role of infection in acute exacerbations of chronic obstructive pulmonary disease. Am J Manag Care 6(8 Suppl):S427-36 (2000) PMID 10977482
  6. ↑ Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 295(1):L1-15 (2008) PMID 18456796
  7. ↑ Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am J Physiol Lung Cell Mol Physiol 294(4):L612-31 (2008) PMID 18223159
  8. ↑ Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172(1):19-38 (2005) PMID 15778487
  9. ↑ The GOLD classification has not advanced understanding of COPD. Am J Respir Crit Care Med 170(3):212-3; discussion 214 (2004) PMID 15280172
  10. ↑ The GOLD classification has advanced understanding of COPD. Am J Respir Crit Care Med 170(3):211-2; discussion 214 (2004) PMID 15280171
  11. ↑ ACP Journal Club. Review: Inhaled corticosteroids do not reduce mortality but increase pneumonia in chronic obstructive pulmonary disease. Ann Intern Med 150(6):JC3-6 (2009) PMID 19306488
  12. ↑ ACP Journal Club. Review: Inhaled anticholinergics increase risk for major cardiovascular events in chronic obstructive pulmonary disease. Ann Intern Med 150(2):JC1-6, JC1-7 (2009) PMID 19172711
  13. ↑ Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 148(7):529-34 (2008) PMID 18316747
  14. ↑ In the clinic. Chronic obstructive pulmonary disease. Ann Intern Med 148(5):ITC3-1-ITC3-16 (2008) PMID 18316750
  15. ↑ Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline. Ann Intern Med 147(9):639-53 (2007) PMID 17975187
  16. ↑ Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 147(9):633-8 (2007) PMID 17975186
  17. ↑ Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 144(12):894-903 (2006) PMID 16785478
  18. ↑ Noninvasive ventilation in exacerbations of chronic obstructive pulmonary disease: implications of different meta-analytic strategies. Ann Intern Med 141(5):W78-9 (2004) PMID 15353447
  19. ↑ Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med 138(12):969-73 (2003) PMID 12809453
  20. ↑ Which patients with acute exacerbation of chronic obstructive pulmonary disease benefit from noninvasive positive-pressure ventilation? A systematic review of the literature. Ann Intern Med 138(11):861-70 (2003) PMID 12779296
  21. ↑ Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med 137(9):715-25 (2002) PMID 12416945
  22. ↑ Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med 134(7):600-20 (2001) PMID 11281745
  23. ↑ Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 134(7):595-9 (2001) PMID 11281744
  24. ↑ COPD as a disease of accelerated lung aging. Chest 135(1):173-80 (2009) PMID 19136405
  25. ↑ Pulmonary vascular involvement in COPD. Chest 134(4):808-14 (2008) PMID 18842913
  26. ↑ Update on the management of COPD. Chest 133(6):1451-62 (2008) PMID 18574288
  27. ↑ Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis. Chest 133(3):756-66 (2008) PMID 18321904
  28. ↑ How viral infections cause exacerbation of airway diseases. Chest 130(4):1203-10 (2006) PMID 17035457
  29. ↑ Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest 129(4):1068-87 (2006) PMID 16608960
  30. ↑ Management of acute exacerbations of COPD: a summary and appraisal of published evidence. Chest 119(4):1190-209 (2001) PMID 11296189
  31. ↑ The evidence base for management of acute exacerbations of COPD: clinical practice guideline, part 1. Chest 119(4):1185-9 (2001) PMID 11296188
  32. ↑ Exhaled breath condensate biomarkers in COPD. Eur Respir J 32(2):472-86 (2008) PMID 18669788
  33. ↑ Nonpharmacological treatment and relief of symptoms in COPD. Eur Respir J 32(1):218-28 (2008) PMID 18591339
  34. ↑ Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 31(6):1334-56 (2008) PMID 18515558
  35. ↑ Drugs (including oxygen) in severe COPD. Eur Respir J 31(5):1114-24 (2008) PMID 18448506
  36. ↑ Remodelling of peripheral lung tissue in COPD. Eur Respir J 31(5):913-4 (2008) PMID 18448496
  37. ↑ Peroxisome proliferator-activated receptors: a therapeutic target in COPD? Eur Respir J 31(3):502-8 (2008) PMID 18310397
  38. ↑ Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 31(2):416-69 (2008) PMID 18238951
  39. ↑ Complex chronic comorbidities of COPD. Eur Respir J 31(1):204-12 (2008) PMID 18166598
  40. ↑ Definition, epidemiology and natural history of COPD. Eur Respir J 30(5):993-1013 (2007) PMID 17978157
  41. ↑ Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 29(6):1224-38 (2007) PMID 17540785
  42. ↑ Mortality in COPD: Role of comorbidities. Eur Respir J 28(6):1245-57 (2006) PMID 17138679
  43. ↑ Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 28(1):219-42 (2006) PMID 16816350
  44. ↑ Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 27(4):822-32 (2006) PMID 16585091
  45. ↑ The natural history of chronic obstructive pulmonary disease. Eur Respir J 27(3):627-43 (2006) PMID 16507865
  46. ↑ COPD: current therapeutic interventions and future approaches. Eur Respir J 25(6):1084-106 (2005) PMID 15929966
  47. ↑ New strategies to improve exercise tolerance in chronic obstructive pulmonary disease. Eur Respir J 24(2):313-22 (2004) PMID 15332404
  48. ↑ Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1. Eur Respir J 23(4):497-8 (2004) PMID 15083741
  49. ↑ Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22(4):672-88 (2003) PMID 14582923
  50. ↑ Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 21(5):892-905 (2003) PMID 12765440
  51. ↑ Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 21(2):347-60 (2003) PMID 12608452
  52. ↑ Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur Respir J 20(3):570-6 (2002) PMID 12358330
  53. ↑ Noninvasive ventilation in chronic ventilatory failure due to chronic obstructive pulmonary disease. Eur Respir J 20(3):511-4 (2002) PMID 12358321
  54. ↑ Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. Eur Respir J 19(1):182-91 (2002) PMID 11843317
  55. ↑ Noninvasive ventilation and obstructive lung diseases. Eur Respir J 17(6):1271-81 (2001) PMID 11491176
  56. ↑ Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 8(8):1398-420 (1995) PMID 7489808
  57. ↑ Pathology and pathophysiology of chronic obstructive pulmonary disease. Intern Med 41(4):265-9 (2002) PMID 11993785
  58. ↑ Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 300(20):2407-16 (2008) PMID 19033591
  59. ↑ Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 290(17):2301-12 (2003) PMID 14600189
  60. ↑ Chronic obstructive pulmonary disease: an evidence-based approach to treatment with a focus on anticholinergic bronchodilation. Mayo Clin Proc 83(11):1241-50 (2008) PMID 18990323
  61. ↑ Cost-effectiveness of long-acting bronchodilators for chronic obstructive pulmonary disease. Mayo Clin Proc 82(5):575-82 (2007) PMID 17493425
  62. ↑ Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation. Postgrad Med J 80(947):497-505 (2004) PMID 15356350
  63. ↑ Treatment of chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc 5(8):848-56 (2008) PMID 19017740
  64. ↑ Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5(4):549-55 (2008) PMID 18453370
  65. ↑ Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5(4):543-8 (2008) PMID 18453369
  66. ↑ Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5(4):530-5 (2008) PMID 18453367
  67. ↑ Oxygen therapy in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5(4):513-8 (2008) PMID 18453364
  68. ↑ New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc 5(4):478-85 (2008) PMID 18453359
  69. ↑ Lung transplantation and lung volume reduction surgery versus transplantation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5(4):447-53 (2008) PMID 18453354
  70. ↑ Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4(8):647-58 (2007) PMID 18073397
  71. ↑ Diagnosis of pathogens in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4(8):642-6 (2007) PMID 18073396
  72. ↑ Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4(7):554-64 (2007) PMID 17878469
  73. ↑ The nonpharmacologic treatment of chronic obstructive pulmonary disease: advances in our understanding of pulmonary rehabilitation. Proc Am Thorac Soc 4(7):549-53 (2007) PMID 17878468
  74. ↑ Pharmacologic therapy: novel approaches for chronic obstructive pulmonary disease. Proc Am Thorac Soc 4(7):543-8 (2007) PMID 17878467
  75. ↑ Inhaled corticosteroids in chronic obstructive pulmonary disease. Proc Am Thorac Soc 4(7):535-42 (2007) PMID 17878466
  76. ↑ Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators. Proc Am Thorac Soc 4(7):526-34 (2007) PMID 17878465
  77. ↑ Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). Proc Am Thorac Soc 4(7):522-5 (2007) PMID 17878464
  78. ↑ The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc 4(7):512-21 (2007) PMID 17878463
  79. ↑ Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 1(2):115-20 (2004) PMID 16113423
  80. ↑ Diaphragm adaptations in patients with COPD. Respir Res 9():12 (2008) PMID 18218129
  81. ↑ Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review. Respir Res 8():30 (2007) PMID 17407610
  82. ↑ Acute exacerbations of COPD. Swiss Med Wkly 133(17-18):247-57 (2003) PMID 12833195
  83. ↑ Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory Society. Swiss Med Wkly 132(5-6):67-78 (2002) PMID 11971200
  84. ↑ Genetic risk factors of chronic obstructive pulmonary disease. Swiss Med Wkly 132(3-4):27-37 (2002) PMID 11953903
  85. ↑ Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis. Thorax 61(10):854-62 (2006) PMID 16844726
  86. ↑ COPD exacerbations.5: management. Thorax 61(6):535-44 (2006) PMID 16738044
  87. ↑ COPD exacerbations . 3: Pathophysiology. Thorax 61(4):354-61 (2006) PMID 16565268
  88. ↑ COPD exacerbations . 2: aetiology. Thorax 61(3):250-8 (2006) PMID 16517585
  89. ↑ Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 59 Suppl 1():1-232 (2004) PMID 15041752
  90. ↑ Chronic obstructive pulmonary disease. 10: Bullectomy, lung volume reduction surgery, and transplantation for patients with chronic obstructive pulmonary disease. Thorax 58(7):634-8 (2003) PMID 12832685
  91. ↑ Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax 58(1):73-80 (2003) PMID 12511727
  92. ↑ Chronic obstructive pulmonary disease. 4: imaging the lungs in patients with chronic obstructive pulmonary disease. Thorax 57(11):982-5 (2002) PMID 12403883
  93. ↑ Development of secondary polycythaemia in chronic airways obstruction. Thorax 36(5):321-5 (1981) PMID 7031963

2 Andere Lexika

Abgerufen von „http://de.pluspedia.org/w/index.php?title=COPD&oldid=32947“

Diesen Artikel melden!
Verletzt dieser Artikel deine Urheber- oder Persönlichkeitsrechte?
Hast du einen Löschwunsch oder ein anderes Anliegen? Dann nutze bitte unser Kontaktformular

PlusPedia Impressum
Diese Seite mit Freunden teilen:
Mr Wong Digg Delicious Yiggit wikio Twitter
Facebook


Bitte Beachte:
Sämtliche Aussagen auf dieser Seite sind ohne Gewähr.
Für die Richtigkeit der Aussagen übernimmt die Betreiberin keine Verantwortung.
Nach Kenntnissnahme von Fehlern und Rechtsverstößens ist die Betreiberin selbstverständlich bereit,
diese zu beheben.

Verantwortlich für jede einzelne Aussage ist der jeweilige Erstautor dieser Aussage.
Mit dem Ergänzen und Weiterschreiben eines Artikels durch einen anderen Autor
werden die vorhergehenden Aussagen und Inhalte nicht zu eigenen.
Die Weiternutzung und Glaubhaftigkeit der Inhalte ist selbst gegenzurecherchieren.


Typo3 Besucherzähler - Seitwert blog counter
java hosting vpn norway